Products for Research Use Only
RegisterLogin

CDK-TCIP1

CAT: 0804-HY-169244-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-169244-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK-TCIP1 is a bivalent molecule linking CDK9 inhibitor SNS-032 to BCL6 ligand BI3812 (HY-111381). CDK-TCIP1 potently and specifically kills BCL6-overexpressing cells with EC50 of 7.7 nM for SUDHL5 cells[1].
CAS Number
3008612-35-6
UNSPSC
12352005
Target
Bcl-2 Family; CDK
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk-tcip1.html
Purity
98.86
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(C)(C1=CN=C(CSC2=CN=C(NC(C3CCN(C(CCCCCCNC(C(CC4)CCN4C5=NC=C(Cl)C(NC6=CC(C=C(OCC(NC)=O)C(N7C)=O)=C7C(OC)=C6)=N5)=O)=O)CC3)=O)S2)O1)C
Molecular Formula
C48H62ClN11O8S2
Molecular Weight
1020.66
References & Citations
[1]Roman C Sarott, et al. Relocalizing transcriptional kinases to activate apoptosis. Science. 2024 Oct 4;386 (6717) :eadl5361.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK9

Related Products

CatalogName
HY-169245-01CDK-TCIP2
HY-170507CDK-IN-16
HY-168067CDK-IN-14
HY-150641-01CDK-IN-9
HY-147386-01CDK-IN-10
HY-13033-01CDK-IN-2
HY-201330CDK-IN-18
HY-149173-01CDK-IN-11
HY-168134CDK-IN-15
HY-78428-01CDK-IN-6

Alternative Products

CatalogName
GTR19239657-01CDK-TCIP1
T204162-01CDK-IN-16
MBS5804923CDK-IN-9
BUP12701-01CDK-IN-2
GTR19239570-01CDK-TCIP2
GTR19261509-01CDK-IN-13
BA3819-5CDK-IN-6
T201193-01CDK-IN-15
T75127-01CDK-IN-12
GTR19187588-01CDK-IN-10

Popular Products